Basic and clinical study of efficacy and adverse effects of flumatinib in Ph+ ALL
Objective: To investigate the efficacy and safety of chemotherapy in treating Ph+ ALL based on flumatinib.Methods: The clinical data of 29 patients with Ph+ ALL receiving flumatinib-based chemotherapy in Sichuan Provincial People's Hospital from January 2020 to January 2023 were collected for a...
Saved in:
Main Authors: | Jun Wang (Author), Jiafei Wu (Author), Yijing Wang (Author), Boyue Zheng (Author), Yu Wang (Author), Chuanyan Jiang (Author), Mengying Zou (Author), Hui Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo
by: Ya-nan Liu, et al.
Published: (2023) -
The innovative bridge in PH positivity- efficacy and side effect profile of inotuzomab ozogamicin and ponatinib combination in relapsed PH positive and PH like all
by: Vijayshree Muthu kumar, et al.
Published: (2024) -
Bicomponent polymeric micelles for pH-controlled delivery of doxorubicin
by: Chunyun Wang, et al.
Published: (2020) -
CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL
by: Hai-ping Dai, et al.
Published: (2023) -
Dynamic micelles with detachable PEGylation at tumoral extracellular pH for enhanced chemotherapy
by: Guoqing Yan, et al.
Published: (2020)